EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.

Oncotarget · 2017 · PMC5777722 · PMID 29383110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, patients with positive EGFR expression showed a trend of poorer OS than did those with negative EGFR expression; however, the difference was not significant (38.1 vs. 54.9 months, p = 0.061) (Figure 2D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.